The forecast for US imports of sulphonamides shows a steady increase from 17.299 million kilograms in 2024 to 18.672 million kilograms by 2028. This growth reflects a consistent upward trajectory, with a CAGR calculated over the forecast period to offer insights into the expected average annual growth. By comparison, in 2023, actual imports were slightly lower, indicating ongoing expansion in demand or supply capacity within this sector. Year-on-year percentage variations are expected to remain positive, reinforcing this gradual increase.
Future trends to watch for include potential shifts in international trade policies that may impact import volumes, technological advancements in pharmaceuticals influencing sulphonamide demand, and emerging alternatives in the market that could disrupt this growth pattern. Monitoring these factors will be crucial for a comprehensive understanding of future import dynamics.
